| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8310804 | Clinica Chimica Acta | 2015 | 5 Pages |
Abstract
This study provides further evidence that anti-DI antibodies can be considered a promising biomarker for risk assessment particularly in patients having vascular thrombosis and triple conventional aPL positivity.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Lauro Meneghel, Amelia Ruffatti, Sabrina Gavasso, Marta Tonello, Elena Mattia, Luca Spiezia, Daniela Tormene, Ariela Hoxha, Marny Fedrigo, Paolo Simioni,